Based in Golden, Colorado, PharmaJet’s mission is worldwide acceptance of PharmaJet Needle-Free devices as a standard of care in the vaccine delivery market.
The innovative PharmaJet Stratis® Needle-Free Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis Needle-Free Injector was approved for delivery of an influenza vaccine to deliver needle-free flu shots.
The PharmaJet Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016. An FDA Master File was established in August of 2017 as a precursor to 510(k) and Tropis received WHO Pre-Qualification (PQS) in June of 2018.
The PharmaJet Needle-Free Injectors are easy-to-use and eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal.
